UNASSIGNED: Our objective is to describe the use of a ventricular assist device (VAD) in single-ventricle @entity1 with @entity1457 following @entity254 ( @entity254 ). We performed a retrospective chart review of all single-ventricle @entity1 supported with a VAD following @entity254 . Implantation techniques, physiologic parameters while supported, medical and surgical interventions postimplant, and outcomes were reviewed. Four @entity1 were supported with an EXCOR Pediatric (Berlin Heart Inc., The Woodlands, TX, USA) following @entity254 for a median duration of 10.5 days (range 9-312 days). Selective excision of trabeculae and chords facilitated apical cannulation in all @entity1 without @entity3885 . There were two pump exchanges in the one @entity1 supported for 312 days. Two @entity1 were evaluated by cardiac catheterization while supported. Three of four @entity1 were successfully bridged to transplantation. One @entity1 died while supported. All @entity1 had significant @entity548 at the time of transplantation, and one required posttransplant extracorporeal membrane oxygenation with subsequent full recovery. VAD support can provide a successful bridge to transplantation in @entity1 with single-ventricle circulation following @entity254 . A thorough understanding of the challenges encountered during this support is necessary for successful outcomes.

Ventricular Assist Device in Single-Ventricle Heart Disease and a XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity1457 :: ('MESH:D012769', 'Disease') :: ['circulatory failure'] @entity254 :: ('MESH:C563598', 'Disease') :: ['superior cavopulmonary anastomosis', 'SCPA'] @entity3885 :: ('MESH:D008173', 'Disease') :: ['inflow obstruction']
@entity254 :: (MESH:C563598,Disease) :: ['Superior Cavopulmonary Anastomosis']
